| A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore N Ngoi, J Lim, S Ow, WY Jen, M Lee, W Teo, J Ho, R Sundar, ML Tung, ... ELSEVIER, 2020 | 58 | 2020 |
| Assessing the impact of a pulmonary embolism response team and treatment protocol on patients presenting with acute pulmonary embolism WY Jen, W Kristanto, L Teo, J Phua, HS Yip, G MacLaren, K Teoh, TB Sim, ... Heart, Lung and Circulation 29 (3), 345-353, 2020 | 39 | 2020 |
| Remote monitoring of marginalised populations affected by COVID-19: a retrospective review SQ Ko, BMY Hooi, CY Koo, DWP Chor, ZJ Ling, YL Chee, WY Jen BMJ open 10 (12), e042647, 2020 | 25 | 2020 |
| A new model for risk stratification of patients with acute pulmonary embolism WY Jen, YS Jeon, P Kojodjojo, EHE Lee, YH Lee, YP Ren, TJS Tan, ... Clinical and Applied Thrombosis/Hemostasis 24 (9_suppl), 277S-284S, 2018 | 19 | 2018 |
| Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease WY Jen, H Kantarjian, TM Kadia, CD DiNardo, GC Issa, NJ Short, ... British Journal of Haematology 205 (1), 30-47, 2024 | 13 | 2024 |
| Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma WY Jen, J Yoong, X Liu, MSY Tan, WJ Chng, YL Chee Patient preference and adherence, 301-308, 2020 | 13 | 2020 |
| Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis M Guo, THM Chan, Q Zhou, O An, Y Li, Y Song, ZH Tan, VHE Ng, ... Blood, The Journal of the American Society of Hematology 141 (25), 3078-3090, 2023 | 10 | 2023 |
| Real-world experience of measurable residual disease response and prognosis in acute myeloid leukemia treated with venetoclax and azacitidine SY Ong, M Tan Si Yun, NA Abdul Halim, D Christopher, WY Jen, ... Cancers 14 (15), 3576, 2022 | 8 | 2022 |
| BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia EA Olesinski, KS Bhatia, AN Mahesh, S Rosli, JS Mohamed, WY Jen, ... Blood advances 7 (12), 2917-2923, 2023 | 7 | 2023 |
| Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients WY Jen, K Sasaki, CR Rausch, CD DiNardo, TM Kadia, M Yilmaz, ... Leukemia & Lymphoma 65 (3), 378-382, 2024 | 6 | 2024 |
| Intravenous maintenance fluid tonicity and hyponatremia after major surgery-a cohort study AS Winata, WY Jen, ML Teng, WC Hing, SG Iyer, V Ma, HR Chua International Journal of Surgery 67, 1-7, 2019 | 6 | 2019 |
| Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia J Marvin-Peek, WY Jen, HM Kantarjian, D McCue, FG Haddad, W Wierda, ... Leukemia & Lymphoma 65 (9), 1325-1334, 2024 | 5 | 2024 |
| Keeping the bloodline of haematology medical education flowing during a pandemic. MA Cheong, YL Chee, HJ Ng, WY Jen International Journal of Laboratory Hematology 42 (5), 2020 | 5 | 2020 |
| Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature WY Jen, M Konopleva, N Pemmaraju Cancer 130 (13), 2260-2271, 2024 | 4 | 2024 |
| FLAG-IDA+ venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML. WY Jen, K Takahashi, S Loghavi, TM Kadia, NG Daver, L Xiao, NJ Short, ... Journal of Clinical Oncology 42 (16_suppl), 6519-6519, 2024 | 4 | 2024 |
| A phase II study of low-intensity chemotherapy (mini-hyper-CVD) and ponatinib followed by blinatumomab and ponatinib in patients with Philadelphia chromosome-positive acute … WY Jen, E Jabbour, FG Haddad, L Nasr, NJ Short, M Zoghbi, C Nasnas, ... Blood 142, 2868, 2023 | 3 | 2023 |
| Phase 2 trial of mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in older patients with newly diagnosed Philadelphia chromosome-negative b-cell acute … WY Jen, E Jabbour, FG Haddad, NJ Short, N Jain, TM Kadia, N Daver, ... Blood 142, 2878, 2023 | 3 | 2023 |
| Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves—a retrospective observational study SY Lee, WZY Teo, CXQ Lim, CT Lee, WY Jen, S de Mel, ES Yap, YL Chee Research and Practice in Thrombosis and Haemostasis 7 (7), 102218, 2023 | 3 | 2023 |
| National University Cancer Institute of Singapore (NCIS) Workflow Team. A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in … N Ngoi, J Lim, S Ow, WY Jen, M Lee, W Teo Ann Oncol 31 (7), 840-3, 2020 | 3 | 2020 |
| Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed, high risk acute myeloid leukemia WY Jen, CD DiNardo, KS Chien, Y Alvarado-Valero, L Masarova, ... Blood 142, 4273, 2023 | 2 | 2023 |
Melissa OoiAdresse e-mail validée de nuhs.edu.sg
